It's good to know that that 45,000,000 was a buy from you

New Post Public Reply Private Reply Replies (0) Message Board
Meach Inventor1 #4557
It's good to know that that 45,000,000 was a buy from you inventor. On the other hand, when should we see some fruit for our toils? Everything I know points to end of August. This is based on all the new information and updated happenings. Whenever I have a timeline, it is essentially to the "next phase" of happening. Not the next PR. I've been basically bang on every single time for events. (Not PR's, because you really cannot predict those).

At this stage in the game; I am really feeling August(Maybe mid sept?) for three things:
1)Dcellvax IND number/ application.
2)Regen going public
3) Full blown clinical trial approval for hemaxellerate from FDA.

I feel like in the spectrum of August to late Sept, we should see all 3 including some more wildcards. I'm not sure if whether or not any of it will pan out this way (Or if more questions will be required,because the FDA is crooked as hell and stem cells would be counterproductive to the current pharmaceutical companies out there)

But it all should line up and be done, bolstering the price to new heights. Please let it come to fruition.

All this in combination with your assumed purchase due to your perceived schedule events rather nicely lines up.

Take it with a grain of salt.

Besides, I hope this is the case because it would save me from my current existence.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading